1 | lesions | 14,149 |
2 | nodules | 852 |
3 | infiltrates | 322 |
4 | calcifications | 171 |
5 | vegetations | 61 |
6 | microcalcifications | 52 |
7 | nevi | 45 |
8 | dysplasias | 40 |
9 | shadows | 39 |
10 | proliferations | 34 |
11 | atheromas | 22 |
12 | embolizations | 16 |
13 | papillomas | 16 |
14 | macroadenomas | 13 |
15 | microcarcinoma | 13 |
16 | deciduosis | 12 |
17 | hyperfluorescence | 11 |
18 | q-waves | 11 |
19 | dermopathy | 9 |
20 | hemangioendothelioma | 7 |
21 | hyperlucency | 7 |
22 | hypodensity | 6 |
23 | nubbins | 6 |
24 | kb220z™ | 5 |
25 | haemothoraces | 4 |
26 | macroaggregates | 4 |
27 | intraradices | 3 |
28 | pathoses | 3 |
29 | alpha-receptors | 2 |
30 | chemoembolization-infusion | 2 |
31 | elastogram | 2 |
32 | hypointensities | 2 |
33 | lesions/year | 2 |
34 | pretherapeutically | 2 |
35 | pveps | 2 |
36 | sensibilities | 2 |
37 | 1.89+/-0.32 | 1 |
38 | agents-reported | 1 |
39 | conditions/lesions | 1 |
40 | cystsonly | 1 |
41 | diseases/events | 1 |
42 | eyepatch | 1 |
43 | invol | 1 |
44 | lesions/conditions | 1 |
45 | lesons | 1 |
46 | n2b-c | 1 |
47 | pi/interval | 1 |
48 | ⩽3cm | 1 |
1 | 1.89+/-0.32 | 1 |
2 | agents-reported | 1 |
3 | alpha-receptors | 2 |
4 | atheromas | 22 |
5 | calcifications | 171 |
6 | chemoembolization-infusion | 2 |
7 | conditions/lesions | 1 |
8 | cystsonly | 1 |
9 | deciduosis | 12 |
10 | dermopathy | 9 |
11 | diseases/events | 1 |
12 | dysplasias | 40 |
13 | elastogram | 2 |
14 | embolizations | 16 |
15 | eyepatch | 1 |
16 | haemothoraces | 4 |
17 | hemangioendothelioma | 7 |
18 | hyperfluorescence | 11 |
19 | hyperlucency | 7 |
20 | hypodensity | 6 |
21 | hypointensities | 2 |
22 | infiltrates | 322 |
23 | intraradices | 3 |
24 | invol | 1 |
25 | kb220z™ | 5 |
26 | lesions | 14,149 |
27 | lesions/conditions | 1 |
28 | lesions/year | 2 |
29 | lesons | 1 |
30 | macroadenomas | 13 |
31 | macroaggregates | 4 |
32 | microcalcifications | 52 |
33 | microcarcinoma | 13 |
34 | n2b-c | 1 |
35 | nevi | 45 |
36 | nodules | 852 |
37 | nubbins | 6 |
38 | papillomas | 16 |
39 | pathoses | 3 |
40 | pi/interval | 1 |
41 | pretherapeutically | 2 |
42 | proliferations | 34 |
43 | pveps | 2 |
44 | q-waves | 11 |
45 | sensibilities | 2 |
46 | shadows | 39 |
47 | vegetations | 61 |
48 | ⩽3cm | 1 |
1 | 1.89+/-0.32 | 1 |
2 | hemangioendothelioma | 7 |
3 | microcarcinoma | 13 |
4 | n2b-c | 1 |
5 | agents-reported | 1 |
6 | hyperfluorescence | 11 |
7 | eyepatch | 1 |
8 | nevi | 45 |
9 | pi/interval | 1 |
10 | invol | 1 |
11 | elastogram | 2 |
12 | ⩽3cm | 1 |
13 | chemoembolization-infusion | 2 |
14 | lesions/year | 2 |
15 | dysplasias | 40 |
16 | papillomas | 16 |
17 | macroadenomas | 13 |
18 | atheromas | 22 |
19 | haemothoraces | 4 |
20 | intraradices | 3 |
21 | sensibilities | 2 |
22 | hypointensities | 2 |
23 | nodules | 852 |
24 | pathoses | 3 |
25 | macroaggregates | 4 |
26 | infiltrates | 322 |
27 | q-waves | 11 |
28 | deciduosis | 12 |
29 | nubbins | 6 |
30 | lesions | 14,149 |
31 | conditions/lesions | 1 |
32 | calcifications | 171 |
33 | microcalcifications | 52 |
34 | proliferations | 34 |
35 | vegetations | 61 |
36 | embolizations | 16 |
37 | lesions/conditions | 1 |
38 | lesons | 1 |
39 | pveps | 2 |
40 | alpha-receptors | 2 |
41 | diseases/events | 1 |
42 | shadows | 39 |
43 | hyperlucency | 7 |
44 | dermopathy | 9 |
45 | pretherapeutically | 2 |
46 | cystsonly | 1 |
47 | hypodensity | 6 |
48 | kb220z™ | 5 |